Amoxycillin clavulanate: an assessment after 15 years of clinical application.
Ball
P
P
University of St. Andrews, Fife, UK.
Geddes
A
A
Rolinson
G
G
D000658:Amoxicillin / Q000009:adverse effects / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D001424:Bacterial Infections / Q000188:drug therapy; D002969:Clavulanic Acids / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy
D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin